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Abstract
Background—Clinical guidelines for prostate cancer screening (PCS) advise physicians to 
discuss the potential harms and benefits of screening. However, there is a lack of training 
programs for informed decision making (IDM), and it is unknown which IDM behaviors 
physicians have the most difficulty performing. Identifying difficult behaviors can help tailor 
training programs.
Purpose—In the context of developing a physician IDM program for PCS, we aimed to describe 
physicians’ use of nine key IDM behaviors for the PCS discussion and to examine the relation 
between the behaviors and physician characteristics.
Methods—A cross-sectional sample of The American Academy of Family Physicians National 
Research Network completed surveys about their behavior regarding PCS (N=246; response 
rate=58%). The surveys included nine physician key IDM behaviors for PCS and a single-item 
question describing their general practice style for PCS.
Results—The most common IDM behavior was to invite men to ask questions. The two least 
common reported behaviors concerned patients uncertain about screening (i.e., arrange follow up 
and provide additional information for undecided men). Physicians reported difficulty with these 
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two behaviors regardless whether they reported to discuss or not to discuss PCS with patients. 
Reported use of key IDM behaviors was associated with a general practice style for PCS and being 
affiliated with a residency training program.
Conclusions—Physician training programs for IDM should include physician skills to address 
the needs of patients uncertain about screening. Future research should determine whether if actual 
behavior is associated with self-reported behavior for the PCS discussion.
INTRODUCTION
Clinical guidelines for the early detection of prostate cancer emphasize the need for primary 
care physicians to advise men about the potential harms and benefits of screening [1–4]. 
Results from national studies suggest that most physicians (70–80%) do discuss prostate 
cancer screening (PCS) with patients [5 6], but there is evidence that the discussions are not 
well balanced. In one study, men reported that physicians were more likely to discuss the 
benefits of screening (71.4%) than the risks (32.0%) [6]. Moreover, lack of time for an 
adequate discussion is a common barrier cited by physicians [7–9].
Most of the research and training for informed decision making (IDM) has focused on the 
patient. Patient decision aids, or tools that help inform patients about options, clarify values, 
and guide them in deliberating and communicating during the decision-making process, are 
shown to be effective in promoting informed or shared decision-making [10]. While patient 
decision aids may help physicians achieve more balanced discussions and reduce the time 
needed to educate men about PCS, primary care physicians still need training to help 
facilitate the process and to best advise the patient in a tailored fashion that is specific to the 
man’s clinical situation. Yet there is little evidence of effective physician training programs 
[11 12] or consistent methods for evaluating physician behavior [11].
In the context of developing a provider IDM training program for PCS that included a 
patient decision aid, we identified nine key behaviors to assess physicians’ use of an IDM 
process for PCS. We then conducted a national survey to describe the use of these behaviors 
among primary care physicians and to examine the relation between the behaviors, general 
practice style for PCS, and physician characteristics. We aimed to use this information to 
identify which behaviors were most important to emphasize in physician training programs 
and to discover if certain groups of physicians need different training based on current key 
behavior use.
METHODS
Development of key behaviors for informed decision making
In a separate study we developed a physician intervention consisting of two parts: a decision 
aid provided to the patient for his review before the clinical visit and a training session for 
the physician on IDM for PCS. To evaluate the training session, we sought to identify the 
essential physician behaviors purportedly required to successfully conduct IDM with 
patients. We drew from several sources: reports of the U.S. Preventive Services Task Force 
(USPSTF) and Community Preventive Services Task Force on shared decision making and 
IDM [13 14], tenets of informed consent, a provider-based IDM trial [15], constructs from 
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cancer screening decision aid trials [10], the “5 A’s” used to structure tobacco cessation 
counseling [16], and consultation with practicing physicians and medical decision-making 
experts. The key behaviors identified were: 1) “tell men there is a decision to make”, 2) “tell 
men that experts disagree about whether men should be screened”, 3) “make sure men have 
information on benefits and risks”, 4) “question men about their understanding”, 5) “ask 
men what they think about screening,” 6) “invite men to ask questions”, 7) “refer undecided 
men to other sources”, 8) “plan follow-up for undecided men”, and 9) “document the 
discussion in the patient’s chart”.
Study design and study population
This cross-sectional study surveyed primary care members of the American Academy of 
Family Physicians National Research Network (AAFP NRN). In July 2007, the AAFP NRN 
project team invited physicians by email to complete an online survey and subsequently sent 
out two email reminders. The team then mailed study packets (invitations, surveys, and 
return envelopes) to non-respondents and members without email addresses. A final packet 
was mailed to all non-responders in January 2008. The AAFP and Baylor College of 
Medicine Institutional Review Boards approved this study. Detailed study procedures are 
elsewhere [17].
Physician survey
The survey asked physicians to self-report how often they engaged in each of the nine key 
behaviors for PCS. The five possible responses ranged from 1-“never” to 5-“always”. To 
identify a general practice style for PCS, physicians were asked a single-item question, 
“Which approach best describes your usual practice regarding prostate-specific antigen 
(PSA) screening with age-appropriate men who have no other risk factors?” The six 
response options were: 1) “I generally do not order the PSA test nor discuss the possible 
harms and benefits with the patient”, 2) “I generally order the PSA test without discussing 
the possible harms and benefits with the patient”, 3) “I generally discuss the possible harms 
and benefits of PSA screening with the patient, and then recommend the test”, 4) “I 
generally discuss the possible harms and benefits of PSA screening with the patient, and 
then recommend against the test”, 5) “I generally discuss the possible harms and benefits of 
PSA screening with the patient and then let him decide whether or not to have the test”, and 
6) “Other”. Finally, respondents were asked for their total years in practice, gender, and 
whether their practice was a residency training site.
Statistical analysis
To compare the physicians’ general practice style for PCS across each of the nine key 
behaviors, we used the three most commonly reported styles. For this analysis of variance, 
each of the nine behaviors was treated as continuous (values = 1 to 5) and all statistical 
significance testing was set at p < .05.
Additionally, we dichotomized the behaviors to represent physicians who frequently 
endorsed behaviors (responded as “often” or “always”) and those who did not (responded as 
“never”, “rarely”, or “sometimes”). To determine the total number of behaviors endorsed, we 
summed the nine dichotomized behaviors.
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RESULTS
Description of the study respondents
Of the 426 then-current AAFP NRN members, 246 (57.7%) completed the questionnaire. 
Members reported an average of 19.4 years in practice (SD = 8.9, range = 2 to 68 years). 
Respondents were predominately male (71.5%), and a little less than half reported residency 
training site affiliation (45.9%). Overall, the characteristics of the respondents to the survey 
were similar to the larger population of AAFP members [17].
General practice style for prostate cancer screening
Almost half of respondents reported that they discuss PCS with patients and allow the 
patient to decide (47.5%); the others were almost evenly divided between screening without 
discussion (24.2%) or discussing PCS and then recommending screening (23.0%). Few 
respondents reported that they discuss screening with patients and then recommend against it 
(3.7%) or that they neither screen nor discuss screening (0.2%).
Reported use of key informed decision-making behaviors
Overall, the most common self-reported behaviors were “invite men to ask questions” (M = 
4.27) and “tell men that there is a decision to make” (M = 3.98). The least common were 
“refer undecided men to other sources” (M = 2.71), “plan follow-up for undecided men” (M 
= 2.94), and “question men about understanding” (M = 3.17). Mean scores for each of the 
nine behaviors were significantly different across the three general practice styles for PCS 
(Table 1). Post-test comparisons revealed significant mean differences for each of the nine 
behaviors between physicians who reported that they screen without discussion and 
physicians who reported that they discuss screening and recommend the PSA test or let the 
patient decide (all p < .05). When comparing the two general practice styles for PCS that 
include discussion of screening (i.e., recommend PSA test and let patient decide), the two 
groups differed significantly on three of the nine key behaviors: “tell men there is a decision 
to make” (p = .03), “tell men that experts disagree” (p < .001), and “ask men what they think 
about screening” (p = .05). Those that recommend the PSA test had higher means for the 
three behaviors compared to those that let the patient decide.
Dichotomized key behavior responses resulted in the total sample endorsing five of the nine 
behaviors (M = 4.90, SD = 2.70). No gender differences were observed for endorsing 
behaviors (F(1,217) = 2.55, p = .11), but there were differences for whether the practice was 
a residency training site (F(1,217) = 40.70, p < .001). Those who reported practicing at a 
residency training site endorsed more behaviors (M = 6.05, SD = 2.23) compared to 
physicians who did not report practicing at such a site (M = 3.92, SD = 2.69).
Endorsement differed across general practice style for PCS (F(2,220) = 74.97, p < .001) 
(Figure 1). Physicians who reported that they discuss screening and then let the patient 
decide endorsed a mean of 6.22 of nine behaviors (SD = 2.05), followed by those who 
reported that they discuss screening and then recommend PCS who were full point lower (M 
= 5.13, SD = 2.22). Physicians who reported that they screen without discussion endorsed 
few behaviors (M = 2.07, SD = 2.05).
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DISCUSSION
In this study, we aimed to describe primary care physicians’ use of nine key behaviors for 
promoting informed decisions about PCS. Overall, physicians only endorsed about half of 
these behaviors, suggesting that the decision-making process between physicians and 
patients may be enhanced by teaching physicians to engage in more of the behaviors, some 
of which could be increased by the use of decision aids. Our results suggest that for all 
physicians, IDM programs should include training on how to make follow-up plans for 
undecided men and provide resources for men to help make screening decisions (e.g., 
websites, decision aids). Training programs should also teach physicians skills on how to 
check men’s understanding about the risks and benefits of screening.
Previously, we identified several general practice styles used by physicians when discussing 
PCS with their patients [18 19]. The single-item question about general practice style for 
PCS was able to group physicians who discuss screening and those who don’t according to 
self-report of ordering PSA tests, screening high-risk men, and attitudes about screening. In 
our current study, we compared key behavior use across general practice style for PCS and 
found that this single item was able to classify physicians according to reported behavior 
use. Therefore, the single-item indicator may be of use to generally classify physicians for 
their PCS style when time is a limiting factor for assessment.
We found few differences between the two general practice styles that discuss screening 
(i.e., recommend screening or let the patient decide). These differences may be an 
interesting research finding, but may not inform intervention development because the 
differences are for key behaviors that are reported to be done frequently for both of the style 
groups. But, the broader finding that many physicians engage in some shared decision-
making behaviors infrequently has greater implications for intervention development.
We found that the total number of behaviors endorsed was associated with practicing at a 
residency-training site affiliation, but not with gender. Other researchers have also found the 
discussion to be associated with practice setting (i.e., multi-group versus solo practice) but 
not with gender [5]. One explanation for the differences by setting is that certain settings 
may have screening discussions as a standard of care. Similarly, residency-training sites may 
emphasize patient-centered care through physician-patient communication skills training as 
part of the curriculum. Outside of residency training sites there is a lack of physician 
incentives for performing IDM behaviors.
The primary limitation of our study is our use of self-report instead of observation, thus 
introducing the potential for over reporting of more desirable behavior. For example, a 
recent study that analyzed audio-recorded encounters to measure IDM found that the process 
for PCS was quite low and that there was little meaningful content during the discussion 
[20]; however, that study did not assess physicians’ self-report of the behaviors. Because of 
the tendency of over report, we chose a conservative cut off to dichotomize IDM behavior 
endorsement. That is, we included responses of “sometimes” as not endorsing a behavior 
(included with responses of “rarely” or “never”) instead of endorsing a behavior (responses 
with “often” and “always”).
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Another limitation is that organizations have issued new guidelines for PCS since our study 
was conducted. The USPSTF now recommends against PSA-based screening, while 
acknowledging that some patients themselves may bring up questions about screening and 
that some physicians will still offer the test [1]. For those who offer the test, the USPSTF 
suggests that physicians should be prepared to engage in a shared decision-making process. 
Based on our results, we recommend that provider-based interventions should teach 
physicians how to engage patients in the decision-making process, share values and 
preferences, and provide resources and follow up to patients not ready to make a decision 
about screening.
In particular, we believe that training programs should offer ways to help facilitate IDM for 
undecided men. Because the new USPSTF guideline conflicts with conventional wisdom 
that “prevention is always beneficial,” there is the potential for more men to be confused 
about screening, question screening, and bring it up to their doctor. This may lead to more 
men being uncertain about screening. Current training programs do not address what to do 
with and how to follow up with undecided men [11].
The nine IDM behaviors we identified can be used to describe physicians’ use of IDM 
process and to evaluate provider decision-making programs. The single-item general 
practice style for PCS may provide a quick assessment of a physician’s general practice style 
for PCS. Future research should determine whether actual physician IDM behavior is 
associated with reported behaviors and general practice styles for PCS and explore the needs 
of the undecided after an IDM process.
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Figure 1. 
Number of endorsed behaviors for informed decision making, by general practice style for 
prostate cancer screening
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